be_ixf;ym_202605 d_11; ct_50
NASDAQ:ARM charts & data provided by TradingView

Latest Insights on ARM

The No. 1 Health Care ETF for the Vaccine Race November 20, 2020 by Annie Stevenson American Investor Today, Investing, Technology (4-minute read) A vaccine may be well on the way today. And it’s showing us exactly how far we’ve come in health care technology. Here’s one way to profit…
We asked you for DoorDash opinions, and boy, we got ‘em! Get the latest on the DoorDash IPO — and if should buy in when DASH goes public. DoorDash Rehash; I’m With the BAND; Uber’s Robo-Taxi No More November 19, 2020 by Joseph Hargett Great Stuff Knocking on Heaven’s Door(Dash) Great Ones … welcome to Reader Feedback day! If you happen to be new ‘round these parts, today’s the day that Great Stuff answers your questions, researches your investment ideas and indulges in your rants … whatever the topic may be. Seriously. Last week, we covered everything from artificial intelligence to […]
Wall Street's vaccine rally was a nice diversion, but it’s time to face facts. We still have a long walk down that road to recovery. Retail’s Reality, Tesla’s 500 and Bezos’ Benzos November 17, 2020 by Joseph Hargett Great Stuff Back to Life, Back to Reality I’m rolling with a little late ‘80s hip-pop today. I know that’s not everyone’s cup of tea, but this ‘89 Soul II Soul classic seemed rather appropriate given this morning’s October retail sales data: Back to life, back to the present time, back from a fantasy. The vaccine rally […]
Can you be too cool for the vaccine race? As it turns out, yes you can! With Moderna’s vaccine coming in hot, Pfizer just got one-upped. Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary November 16, 2020 by Joseph Hargett Great Stuff Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead November 14, 2020 by Jay Goldberg Investment Opportunities, Winning Investor Daily The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

Share This